Refractory Grade 3b Follicular Lymphoma
11 clinical trials · Condition
◉ Watch Refractory Grade 3b Follicular Lymphoma
| Record | Firm | Date |
|---|---|---|
| ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma (NCT05025800) | M.D. Anderson Cancer Center | 2021-10-13 |
| CpG-STAT3 siRNA CAS3/SS3 and Localized Radiation Therapy for the Treatment of Relapsed/Refractory B-Cell NHL (NCT04995536) | City of Hope Medical Center | 2021-07-27 |
Track Refractory Grade 3b Follicular Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.